Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0151744 (myocardial ischemia)
 31,282 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Tissue typing was used to study characteristic features of class I and II HLA-antigens distribution in two populations of young IHD patients: Russians (n-32) and Georgians (n-72). Healthy donors (267 Russians and 579 Georgians) served as controls. Genetic markers of IHD predisposition are revealed: for Russians relative risk for B12, DR1 equaled 2.95 and 3.65, respectively, and for Georgians 6.60, 3.02 and 2.33 for B21, Bw22 and DR2, respectively. The differences in markers of IHD predisposition in two populations belonging to the same race suggest than IHD predisposition gene in each population may be bound to various HLA antigen(s). This necessitates study of the markers not only in each race, but in each population as well.
 ...
PMID:[HLA-associated susceptibility to ischemic heart disease]. 214 39

The peculiarities of human leukocyte antigen (HLA) distribution (classes I and II) in young Georgians (72 patients) and Russians (81 patients) with ischaemic heart disease (IHD) were examined by standard tissue-typing methods. The distributions of HLAs in 267 healthy Russian, and 579 healthy Georgian blood donors were taken as controls. The antigens identified as genetic markers of IHD predisposition among Russians were B12 (relative risk, Rr = 2.91), DR1 (Rr = 3.41), and DR4 (Rr = 3.14), for Georgians B21 (Rr = 6.61) was identified. The difference in predisposition markers between these two populations, both belonging to the same race, indicates that IHD predisposition can be linked with different HLAs in different populations.
 ...
PMID:Human leukocyte antigens as markers of predisposition to ischaemic heart disease in Russian and Georgian populations. 215 26

We investigated the distribution of HLA antigens among 413 patients with ischaemic heart disease or dilated cardiomyopathy referred for cardiac transplantation to determine if possession of certain HLA antigens predisposed to end-stage heart failure. Of the patients studied, 234 had ischaemic heart disease (218 males), mean age 49 years (SD 7.1) and 179 patients had dilated cardiomyopathy (150 males), mean age 39 years (12.8). The control group comprised 2041 kidney donors reported to the United Kingdom Transplant Service between July and August 1985. We found a significant excess of HLA DR1 (odds ratio 1.64, 95% CI 1.16-2.33, attributable risk 5.0%) and DR5 antigens (odds ratio 1.47, 95% CI 0.99-2.18, attributable risk) among patients with dilated cardiomyopathy but not of HLA DR4 as previously reported. We found a lower frequency than expected of HLA B21 (10.44 expected, none observed) among patients with ischaemic heart disease but no other significant differences. This study provides some support for the concept of the risk of developing end-stage heart failure due to dilated cardiomyopathy being associated with possession of HLA DR1 and DR5, but no such evidence in ischaemic heart disease. Larger multi-centre studies are required to confirm the validity of these findings.
 ...
PMID:HLA antigen frequencies in end-stage idiopathic and ischaemic cardiomyopathy. 1007 98